The context for our consideration of health care policy options is the central conclusions derived from Parts 1 and 2. They are:
- The majority of Americans now support at least basic health care as a fundamental right to be provided universally without regard to ability to pay.
- Neither the marketplace for health care delivery nor for health insurance is meaningfully competitive.
- The US health care system currently constitutes a near-worst-case scenario, as we spend roughly 17% of our GDP on health care without universal coverage while the rest of the developed world spends 5-10% with universality.
Keeping this context in mind, I typically find it useful to consider public policy options on a continuum with the most centralized (largest role for government) at one end and the least centralized (largest role for private markets) at the other. This will be useful here so long as one important distinction is made – that between health care delivery and health care funding. Put simply, it is quite possible for health care delivery to be at a much different point on the public-private continuum than is health care funding.
Given this distinction, let’s consider four points along the public-private continuum (there are obviously further policy gradations between these points). At one end is the public delivery-public funding policy option. Here not only is the universal health care program funded publicly through tax dollars, but the health care services themselves are provided by government care providers in government facilities. In spite of the overused and misused label “socialized medicine,” this is in fact the only policy option that actually fits the description. Few national health care systems around the world conform with this option, with the United Kingdom and Sweden being the closest. Somewhat ironically the US Veteran’s Administration (VA) and armed forces health care sub-systems also fit the model. Nevertheless, for purposes of this discussion we will assume for fairly obvious reasons that the public delivery-public funding model is not a good fit politically and ideologically in the US.
At the opposite end of the spectrum is the private delivery-private funding model. Here both the delivery of health care and its financing occurs in the private marketplace, as in pre-1960s America. This is mentioned only for symmetry given our conclusions in Parts 1 and 2. Whether for moral, political and/or economic reasons this model has been rejected as unacceptable and unworkable around the world, and now in the US.
So not surprisingly the extremely centralized and extremely decentralized models will not work in the US, and in fact are found very rarely elsewhere. So what’s in between? Most of the developed world actually, but let’s focus on two significant variations of the private delivery-public funding approach that are particularly relevant for America.
The first is Obamacare-like options. Under this approach health care universality is achieved simply by mandating it to some combination of consumers, providers and/or insurers. What could be more straightforward? In practice of course attempting to impose mandates on a largely private delivery system is fraught with complications. As Nobel laureate Paul Krugman notes, such efforts are essentially “a matter of redistributing from the lucky to the unlucky,” and they come with both direct and indirect costs. For example, mandating that health insurers must cover preexisting conditions or dependent family members to age 26 means higher premiums for healthier and dependent-less individuals. It also creates perverse incentives (for dependents to stay at home and for everyone to remain uninsured until sick), which shrinks the risk pool and drives premiums even higher. So you must also mandate participation, which in turn requires providing both penalties to non-participants and subsidies paid for by taxes for those who can’t afford the premiums.
This complex system is the essence of the non-Medicaid part of Obamacare, and it is based on the typically unspoken premise that the private health care marketplace can still provide universal health care efficiently if only the right combination of mandates, penalties and subsidies can be found. But we’ve already observed that these markets are not competitive to begin with, and that they have resulted in exorbitant costs without corresponding health care quality. And yet we are supposed to believe that extensive but largely experimental government regulations will cure this very sick patient (sorry for the predictable metaphor)?
Fortunately there is another private delivery-public funding option that makes much more sense – the single payer approach. This policy option can have many variations, but the principles are straightforward. There is ample evidence that the high health care costs in the US are significantly related to the fragmented and noncompetitive US marketplace still dominated by private health insurers. Therefore simple logic, as well as much accumulated experience from other nations, suggests that achieving affordable and universal health care requires replacing the fragmented private insurance system with a single payer fund to pay for the health care costs. While the single payer fund can be controlled by any agency, it is typically organized and overseen by the government. According to the World Health Organization more than half the industrialized countries in the world have some form of single-payer system of universal health care.
Why would a single payer system be better for the US? Put simply, as compared to our current disjointed private-public system it would result in equal or better health care at a much lower cost. The cost advantage occurs for several basic reasons. First, to make a profit private insurers must screen out high-cost unhealthy customers, spending large sums of money on what’s called underwriting to deny coverage and limit benefits. Public single-pay insurance systems, which by definition cover everyone, avoid these costs. Further administrative cost savings are possible because with less fragmentation there is much less paperwork imposed on health care providers. As a result public systems typically spend 2-4% of their resources on administration, while private insurance companies spend 10-15%. In addition, a large single payer such as the US government has much greater bargaining power in negotiating lower prices with suppliers, especially pharmaceutical companies. This is one of the primary reasons why US residents not covered by Medicare, Medicaid or the VA pay much higher prices for prescription drugs than do those of most other industrialized countries.
Why has the US been so reluctant to adopt what most of the developed world has seen for decades as a superior model for universal health care provision, especially since we basically already have a form of single payer for low-income, elderly and active duty military/veterans? The criticisms fall into two basic categories – political and financial. On the political front opposition has come from predictable sources – private insurance companies, some health care providers who benefit from the current dysfunction, and ideological conservatives who fear ‘socialized medicine’ no matter what the cost of the market-dominated status quo. While these special-(self)interest groups continue to have and exert considerable political power, they simply don’t have much credibility when their views are weighed against the evidence.
The financial criticism is also predictable, albeit incomplete – a single payer system is expensive and will require substantial tax increases to fund. True and true. But if the current system results in exorbitant overall costs and a single payer system will lower those costs, the overall new system costs should be substantially lower. Yes, but lower system costs will not equate to lower costs for everyone. As with any public policy, including the market solution, there are winners and losers.
For example, the relatively generous Bernie Sanders “Medicare for All” proposal is estimated by the Sanders camp to cost $1.38 trillion annually. Ouch you say! BUT they also estimate that the plan will cost over $6 trillion LESS over the next ten years than the current system. The winners under this plan would include the currently uninsured or under-insured, lower and middle income Americans whose taxes wouldn’t go up but whose out-of-pocket health care costs would go down, and those employers whose employee health insurance savings would exceed the new plan’s proposed employer tax. The losers under the proposal would be some employers, some health care providers, insurance companies, pharmaceutical firms and the wealthy (>$250,000 in annual income) whose marginal tax rates go up under the plan.
So maybe we’ve finally identified the often unspoken core of our infatuation with an outmoded, dysfunctional and outrageously expensive health care system: it imposes disproportionate costs on the least powerful (the sick, the uninsured or under-insured, low and middle income Americans) while rewarding powerful insurance companies, large health care providers, pharmaceutical firms and the wealthy. And of course a meaningful universal health care system would essentially reverse these winner and loser categories. So we can’t avoid the dreaded (especially in the US) R word – redistribution. But political power and narrow self-interest are not forces limited to the US. They have been overcome elsewhere and recent experience suggests that the stars are aligning here as well.
President Trump recently noted that health care reform is “complicated.” Yes and no. The details can be mind-numbing. And reasonable people can disagree about the merits of a redistributional public policy that imposes higher overall costs on society, as they sometimes do. But that’s not the case here. When the result would almost certainly be much lower social costs with equivalent or better care it should actually be a no-brainer.